Pharma News
Looking out for latest news on Pharma Magazine?
Check out the latest Pharma news, Top news in Pharma Magazine, Leading Magazine in Pharma industry. Daily news updates pertinent to the industrial sectors we are engaged with are depicted on the news section of Pharma industry which we operate.
Hanmi Pharmaceutical Advances Clinical Trials for BH3120, a Next-Generation Cancer Immunotherapy
Monday, November 25, 2024Hanmi Pharmaceutical and Beijing Hanmi Pharmaceutical have made significant progress in the clinical development of BH a novel immunotherapy targeting advanced cancers
Biofidelity Launches Aspyre® Clinical Test for Rapid Lung Cancer Profiling
Friday, November 22, 2024Biofidelity has introduced the Aspyre Clinical Test for LungThis advanced test is designed for nonsmall cell lung cancer NSCLC patients providing molecular profiling for all guidelinerecommended genes using tissue or liquid biopsy samples T
Zevra Therapeutics Launches MIPLYFFA™ (arimoclomol) in the US for Niemann-Pick Disease Type C
Friday, November 22, 2024Zevra Therapeutics has announced the commercial availability of MIPLYFFA arimoclomol in the United States MIPLYFFA works by activating transcription factors that upregulate lysosomal gene expression which helps to reduce cholesterol buildup in NPC ce...
InxMed's Ifebemtinib Gains Breakthrough Therapy Status for KRAS G12C NSCLC in China
Friday, November 22, 2024InxMed has announced that its focal adhesion kinase FAK inhibitor Ifebemtinib IN has received Breakthrough Therapy Designation BTD from Chinas National Medical Products Administration NMPA
Kura Oncology and Kyowa Kirin Announce Strategic Partnership for Ziftomenib Development in Acute Leukemias
Thursday, November 21, 2024Kura Oncology and Kyowa Kirin have formed a global collaboration to develop and commercialise ziftomenib an investigational oral menin inhibitor targeting acute myeloid leukaemia AML and other haematologic malignancies
Pfizer’s HYMPAVZI™ Approved by European Commission for Severe Haemophilia A and B
Thursday, November 21, 2024Pfizer has announced that the European Commission EC has granted marketing authorisation for HYMPAVZI marstacimab its treatment for adolescents and adults aged years and older with severe haemophilia A or B without inhibitors
Jazz Pharmaceuticals Gains U.S. FDA Approval for Ziihera® in HER2-Positive Biliary Tract Cancer
Thursday, November 21, 2024Jazz Pharmaceuticals has announced that the US Food and Drug Administration FDA has granted accelerated approval for Ziihera zanidatamabhrii a treatment for adults with previously treated unresectable or metastatic HERpositive biliary tract cancer BT...
Sangamo Therapeutics Gains FDA Approval for ST-503 IND in Idiopathic Small Fibre Neuropathy
Wednesday, November 20, 2024Sangamo Therapeutics has received clearance from the US Food and Drug Administration FDA for its investigational new drug IND application for ST Neuropathic pain arises from various conditions affecting the central or peripheral nervous systems inclu...
Ractigen Secures FDA Orphan Drug Designation for RAG-21 in ALS
Wednesday, November 20, 2024Ractigen Therapeutics has announced that the US Food and Drug Administration FDA has granted Orphan Drug Designation ODD to RAG a novel small interfering RNA siRNA therapy
Celltrion to Acquire iQone Healthcare Switzerland to Strengthen European Presence
Wednesday, November 20, 2024Celltrion has announced plans to acquire iQone Healthcare Switzerland The acquisition is anticipated to be finalised by the fourth quarter of Following the completion of the transaction iQone Healthcare Switzerland will operate as a whollyowned subs...
